Latham, NY – JDRF’s Northeastern New York Chapter recently elected three prominent community leaders to serve on its Board of Directors. Rosemarie Riddell Bogdan, Laura J. Caponera, and James J. Carr will each serve a two-year term beginning July 1. JDRF Chapter Board members play a vital role in executing fundraising, leadership and advocacy activities to ensure that the organization’s efforts remain aligned with the needs of people who live with type 1 diabetes (T1D).

Rosemarie Riddell Bogdan is a partner at Martin, Harding & Mazzotti where she concentrates in the area of personal injury litigation. She graduated from Cornell University in 1989 with a Bachelor of Science degree, and from Albany Law School with a Juris Doctor degree in 1992. Ms. Bodgan has been actively involved with JDRF since her son was diagnosed with T1D at age 3.

Laura J. Caponera is an active volunteer with JDRF. She created the Chapter’s black-tie gala nearly 20 years ago when her daughter Kristen was diagnosed with T1D at the age of 8. Ms. Caponera has previously served on the Board of Directors and past president of the Chapter, in addition to playing leadership roles in advocacy, fundraising and as the chairperson of countless event committees.

James J. Carr is a member of Hinman Straub’s Education, Health and Government Relations departments. Mr. Carr is currently also chair of the board of directors of St. Catherine’s Center for Children and is a former chair of the American Diabetes Association Capital District Chapter Board of Directors.
“We congratulate our newest Board members and are delighted to welcome them to the JDRF Northeastern New York Chapter,” said Ray Kimmelblatt, Executive Director. “As we look to draw more volunteers and improve the lives of every person affected by T1D, we’re confident that our board provides a balanced mix of strengths and talents to expand our engagement of the T1D community and help JDRF toward our common goal of creating a world without T1D.”

About JDRF
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested nearly $2 billion since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers in JDRF Northeastern New York, and in more than 100 locations throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF.